Tango Therapeutics, Inc.
TNGX
$25.60
-$0.05-0.20%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -42.44% | -14.14% | -2.86% | 154.46% | -52.06% |
| Total Depreciation and Amortization | -32.00% | -25.56% | -22.74% | -10.77% | -1.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 146.42% | 40.84% | -18.53% | 1.50% | -5.98% |
| Change in Net Operating Assets | 83.20% | 0.41% | 133.59% | -362.12% | 13.92% |
| Cash from Operations | -6.43% | -6.39% | 18.91% | 7.30% | -54.70% |
| Capital Expenditure | -- | -- | -79.03% | -31.30% | -95.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2,662.88% | -68.57% | -359.65% | 45.72% | 33.67% |
| Cash from Investing | -2,758.08% | -68.51% | -360.69% | 45.77% | 32.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 115,676.94% | 4,019,050.00% | 22,543.14% | 5.79% | -55.68% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 115,660.59% | 3,992,200.00% | 22,539.42% | 5.79% | -55.68% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,079.80% | 506.57% | 229.27% | 1,105.18% | -99.65% |